supraoutletshop.com

Saturday, March 3, 2018

On Wednesday, French sports clothing brand Lacoste announced producing a limited edition of polo shirts featuring top-ten endangered animal species as the logo, instead of the company’s usual crocodile logo, in a measure to protect those animals, partnering with the International Union for Conservation of Nature (IUCN).

Lacoste announced partnering with IUCN at the Paris Fashion Week. Proceeds from the sale would be donated to the IUCN, online magazine Dezeen reported. The collaboration was a part of IUCN’s “Save our Species” (SOS) programme.

The endangered animals to feature on the polo shirts were: vaquita, Burmese roofed turtle, northern sportive lemur, Javan rhino, Cao-vit gibbon, kakapo, California condor, saola, Sumatran tiger, and Anegada ground iguana.

The limited edition polos were to be produced in the count of the endangered animals, meaning 30 shirts featuring the vaquita, a mammal found near the Californian Gulf, would be produced as only 30 vaquitas are believed remaining. In total, 1775 polos featuring an endangered animal as the logo would be produced.

Lacoste was founded by tennis player René Lacoste and André Gillier in 1933 and their crocodile logo was never changed until now, in the 85-year-history of the clothing brand.

The limited edition shirts were to be available in only some European countries and the United States.

Note: Statistics from Lacoste’s website

Thursday, July 31, 2008

From the middle of July, Sony Corporation refreshed their senior laptop brand VAIO from “Video Audio Integrated Operation” to “Visual Audio Intelligent Organizer”. According to Sony Taiwan Limited, this refreshment is an attempt to relocate the laptop consuming market for business and entertainment factors.

In the “VAIO Experience 2008” press conference in Europe, Sony promoted their new product series for different populations including BZ for business, FW for home entertainment, Z for ultra-slim, and SR for complex applications.

Different with past series, Sony added “Clear Bright” screening technology for high-definition display, and “full-carbon production” features. BD-burning and Intel Centrino 2 processing technologies will be featured in all the new models. For security issue, Sony also embedded fingerprint system to prevent personal data to be stolen. Continued from TZ series, innovative designs including “Green Power Button”, “Situational Switch” are also added in newly-launched series.

“Due to consuming market differences, Sony only promoted BZ series in Europe and America but not included Asia. Although the TICA Show in Taipei will be different, functionality will be the greatest issue when a consumers choose a notebook [computer] before buying.” addressed by executives from Sony Taiwan Limited, during the “VAIO Experience 2008” press conference in Taiwan.

A compilation of brief news reports for Sunday, March 14, 2010.

Monday, June 17, 2013

The Duke of Edinburgh, the husband of the current British monarch, today departed from the London Clinic, located in the centre of the British capital, after eleven days. Prince Philip, who is aged 92, was hospitalised on June 6 to be given exploratory surgery on his abdomen.

According to the BBC, it was thought the Prince would remain in hospital for two weeks. The abdominal surgery was pre-planned, Buckingham Palace previously reported, although the reasons why this surgery was arranged have not been publicised.

The Duke of Edinburgh missed numerous royal occasions while he was in the private building, including the Trooping the Colour on June 15 to celebrate the Queen’s Official Birthday. As he was staying in the Clinic, over a thousand cards were sent to the Duke. Also, members of the British Royal Family, including Charles, Prince of Wales; Prince Edward, Earl of Wessex; Prince William, Duke of Cambridge; Prince Harry of Wales; and his wife, Elizabeth II, visited him.

A Buckingham Palace statement said the Duke was in “good condition and good spirits”, adding that he would take a two month time period to recover. “The Duke has expressed his thanks and appreciation to medical staff at the London Clinic and the many members of the public who have sent good wishes”, the statement added. ITV News Royal Correspondent Tim Ewart commented, “for a man of 92, who spent 11 nights in hospital, the Duke looked extraordinarily fit.”

Monday, October 11, 2010

Wikinews interviewed author Amy Scobee about her book Scientology – Abuse at the Top, and asked her about her experiences working as an executive within the organization. Scobee joined the organization at age 14, and worked at Scientology’s international management headquarters for several years before leaving in 2005. She served as a Scientology executive in multiple high-ranking positions, working out of the international headquarters of Scientology known as “Gold Base”, located in Gilman Hot Springs near Hemet, California.

Thursday, August 15, 2019

On Monday morning, Director Anthony Fauci of the United States National Institute of Allergy and Infectious Diseases (NIAID), announced a trial of four possible Ebola drugs was stopped early because two of them had already shown considerable progress in treating the disease and saving the lives of those infected. Ebola virus disease (EVD) is a hemorrhagic fever with a high mortality rate and spreads via human-to-human contact.

The PALM trial, for the Swahili phrase pamoja tulinde maisha or “together save lives,” began last November and collected data from 499 patients from the towns of Beni, Butembo, Mangina, and Katwa in the Democratic Republic of the Congo, which has suffered an Ebola outbreak for roughly the past year.

Professor Jean-Jacques Muyembe, Director General of the DRC’s Institut National de Recherche Biomédicale that monitored the trial, said, “From now on, we will no longer say that Ebola is incurable[.]” He went on to say thousands of deaths could be prevented.

While one experimental vaccine appears able to reduce Ebola mortality, up until now, no drugs have been clearly demonstrated suitable for treating existing infection. One antibody cocktail, ZMapp, initially showed promise in the field, but formal studies indicated it had less benefit than sought in preventing death. In the PALM trial, ZMapp served as a control, meaning scientists used it as a baseline and compared the three other treatments to it.

The other three treatments were remdesivir, an antiviral drug; mAb114, a monoclonal antibody first isolated from human survivors of an outbreak in Kikwit in 1995, now produced by the Florida company Ridgeback Biotherapeutics; and REGN-EB3, a cocktail of three monoclonal antibodies from Ebola-infected laboratory mice whose immune systems had been altered to be similar to humans’.

The overall mortality rates were 49% for patients treated with ZMapp, 53% for remdesivir, 29% for REGN-EB3, and 34% for mAb114, but patients treatment early with low viral loads had a death rate of only 6% to 11% when treated with REGN-EB3 or mAb114.

Mike Ryan of the World Health Organization (WHO) told the press the new drugs were only part of the solution: “What will stop Ebola, under professor Muyembe’s leadership and that of the government of the DRC, is good surveillance, good infection prevention and control, good community engagement, excellent vaccinations, and the use of these therapeutics in the most effective way possible.”

Past EVD outbreak mortality rates have been at least 25%, as high as 90%, and averaged around 50% according to WHO’s statistics. According to Muyembe, many people do not seek treatment because they see their friends and relatives die after entering a care facility. “Now that 90% of their patients can go into the treatment center and come out completely cured,” he told the press, “they will start believing it and building trust in the population and community[.]”

Per the WHO’s Monitored Emergency Use of Unregistered and Investigational Interventions framework, all treatment centers in the DRC are to be permitted to administer mAb114 and REGN-EB3 to patients, even though research into the two treatments is not yet complete, and ZMapp and remdesivir are to be retired. A follow-on study, to be performed in the same four treatment centers as PALM, is to involve randomly assigning patients either a mAb114 or REGN-EB3 regimen.

In the DRC’s current Ebola outbreak, two thirds of those known to be infected with Ebola, over 1800 people, have died.

Wednesday, October 3, 2007

Wayne Simmons is running for the Freedom Party in the Ontario provincial election, in the Don Valley East riding. Wikinews’ Nick Moreau interviewed him regarding his values, his experience, and his campaign.

Wayne did not answer “Of the decisions made by Ontario’s 38th Legislative Assembly, which was the most beneficial to your this electoral district? To the province as a whole? Which was least beneficial, or even harmful, to your this riding? To the province as a whole?”

Stay tuned for further interviews; every candidate from every party is eligible, and will be contacted. Expect interviews from Liberals, Progressive Conservatives, New Democratic Party members, Ontario Greens, as well as members from the Family Coalition, Freedom, Communist, Libertarian, and Confederation of Regions parties, as well as independents.